Fibrostenotic Crohn Disease

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2023-06-26
Clinical Trial Update: A Study to Test Whether Spesolimab Helps People With Crohn's Disease Who Have Symptoms of Bowel Obstruction [Phase 2]
A Phase 2 trial of Spesolimab in fibrostenotic Crohn's disease was terminated. Results from the terminated trial have been posted.